Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) Short-term Investments (2009 - 2022)

Agilent Technologies' (A) quarterly Short-term Investments came in at $6.0 million in Q3 2022, down 71.43% quarter-over-quarter from $21.0 million in Q2 2022.

Analysis

Agilent Technologies (A) Short-term Investments (2009 - 2022) Analysis & Trends

Agilent Technologies (A) has reported Short-term Investments for 5 consecutive years, with $6.0 million the latest figure, recorded in Q3 2022.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $6.0 million in Q3 2022; TTM through Jul 2022 was $6.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $91.0 million, changed N/A from the prior year.
  • Short-term Investments was $6.0 million for Q3 2022 at Agilent Technologies, down from $21.0 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $91.0 million in Q4 2021 and troughed at $1.0 million in Q2 2018.
  • A 3-year average of $32.8 million and a median of $21.0 million in 2022 frame the typical range for Short-term Investments.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2022 6.00 Mn
Apr 30, 2022 21.00 Mn
Jan 31, 2022 45.00 Mn
Oct 31, 2021 91.00 Mn
Apr 30, 2018 1.00 Mn
Apr 30, 2010 11.00 Mn
Jan 31, 2010 12.00 Mn
Oct 31, 2009 14.00 Mn
Jul 31, 2009 20.00 Mn